Michael Wagner
University Hospital Carl Gustav Carus · 143 works · 5,314 citations · h-index 34
Top works
- Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C
- Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin
- Hepatitis C virus dynamics in vivo : Effect of ribavirin and interferon alfa on viral turnover
- IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
- Structure and thermodynamic properties of nanocrystalline metals
- International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C
- Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
- Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure
- Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5
- Blockers of the Delayed-Rectifier Potassium Current in Pancreatic β-Cells Enhance Glucose-Dependent Insulin Secretion
- Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma
- Effect of Renal Denervation on Neurohumoral Activation Triggering Atrial Fibrillation in Obstructive Sleep Apnea
- Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1α, is a direct and sufficient stimulus for brain-type natriuretic peptide induction
- HDAC4 controls histone methylation in response to elevated cardiac load
- Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus
- Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C
- Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy
- HCV-Specific T-Cell Response in Relation to Viral Kinetics and Treatment Outcome (DITTO-HCV Project)
- Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
- In toxic demyelination oligodendroglial cell death occurs early and is FAS independent